Don't Use Delafloxacin to Treat Most Skin Infections

Delafloxacin (Baxdela, baks-DEH-lah) is a new quinolone antibiotic.

Think of it as similar to levofloxacin, but so far it's only approved to treat skin infections.

And lab data suggest delafloxacin may have better methicillin-resistant Staph aureus (MRSA) coverage than other quinolones.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals